Thiazole compounds useful as inhibitors of protein kinase
US7256190B2 · kind B2 · utility
31Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2004 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Jul 13, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I:or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3, Aurora2, and Syk mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.